Developmentally regulated expression of IGF binding protein-3 (IGFBP-3) in human placental fibroblasts: Effect of exogenous IGFBP-3 on IGF-1 action

Regulatory Peptides

Volumn 61, Issue 3, 1996, Pages 189-195

  Rogers, Jena ^b   Wiltrout, Lisa ^a   Nanu, Lydia ^b   Fant, Michael E ^a  

^a ST LOUIS CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Human; IGF binding protein 3; Placenta; Preterm

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ARTICLE; CELL PROLIFERATION; FIBROBLAST; GESTATION PERIOD; GROWTH RATE; HUMAN; HUMAN CELL; MITOGENESIS; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION;

EID: 0029983355     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-0115(95)00155-7     Document Type: Article

References (34)

1. Fant, M.E., In vitro growth rate of placental fibroblasts is developmentally regulated, J. Clin. Inv., 88 (1991) 1697-1702.
2. Widdowson, E.M., Crabb, D.E. and Milner, R.D.G., Cellular development of some human organs before birth, Arch. Dis. Child., 47 (1972) 652-655.
3. Gellen, J. and Gyori, I., The weight increase of the placenta and embryo in early human pregnancy, J. Obstet. Gynaecol. Br. Commonw., 76 (1969) 990-992.
4. Binoux, M., Hossenlopp, P., Hardouin, S., Seurin, D., Lassarre, C. and Gourmelen, M., Somatomedin (insulin-like growth factors)-binding proteins: molecular forms and regulation, Horm. Res., 24 (1986) 141-151.
5. Ooi, G.T. and Herrington, A.C., The biological and structural characterization of specific serum binding proteins for the insulin-like growth factors, J. Clin. Endocrinol. Metab., 118 (1988) 7-18.
6. Baxter, R.C., Insulin-like growth factor (IGF) binding proteins in regulating IGF availability, Acta Paediatr. Scand. (Suppl.), 372 (1991) 107-114.
7. Drop, S.L.S., Brinkman, A., Kortleve, D.J., Groffen, Schuller, A. and Warthoff, Z. The evolution of the insulin-like growth factor binding protein family. In E.M. Spencer (Ed.), Modern Concepts of Insulin-Like Growth Factors, Elsevier, New York, 1991, pp. 311-328.
8. Shimasaki, S. and Ling, N., Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6), Prog. Growth Factor Res., 3 (1991) 243-266.
9. Binkert, D., Landwehr, J., Mary J-L, Schwander, J. and Heinrich, G., Cloning, sequence analysis and expression of a cDNA encoding a novel insulin-like growth factor binding protein (IGFBP-2), EMBO J., 8 (1989) 2497-2502.
10. Brinkman, A., Groffen, G., Cortleve, D.J., Geurts-van-Kessel, A. and Drop, S.L.S., Isolation and characterization oa CDNA encoding the low molecular weight insulin-like growth factor binding proteins (IBP-1), EMBO J., 7 (1988) 2417-2423.
11. La Tour, D., Mohan, S., Linkhart, T.A., Baylink, D.J. and Strong, D.D., Inhibitory insulin-like growth factor binding protein (hIGFBP-4): cloning, complete sequence, and physiological regulation, Mol. Endocrinol., 4 (1990) 1806-1814.
12. Lee, Y-L., Hintz, R.L., James, P.M., Lee, P.D.K., Shirley, J.E., Powell, D.R., Insulin-like growth factor (IGF) binding protein complementary deoxyribonucleic acid from human HEP G2 hepatoma cells: predicted protein sequence suggests an IGF binding domain different from those of IGF-I and IGF-II receptors, Mol. Endocrinol., 2 (1988) 404-411.
13. Blum, W.F. and Ranke, M., Plasma IGFBP-3 levels as clinical indicators. In E.M. Spencer (Ed.), Modern Concepts of Insulin-like Growth Factors, Elsevier, New York, 1991, pp. 371-380.
14. White, R.M., Nissley, S.P., Moses, A.C., Rechler, M.M. and Johnsenbaugh, R.E., The growth hormone dependence of a somatomedin-binding protein in human serum, J. Clin. Endocrinol. Metab., 53 (1981) 49-57.
15. Suikkari, A.M., Koivisto, V.A., Rutanen, E.M., Yki-Jarvinen, H., Karonen, S.L. and Seppala, M., Insulin regulates the serum levels of low molecular weight insulin-like growth factor binding protein, J. Clin. Endocrinol. Metab., 66 (1988) 266-272.
16. Lewitt, M.S. and Baxter, R.C., Inhibitors of glucose uptake stimulate the production of insulin-like growth factor binding protein (IGFBP-1) by human fetal liver, Endocrinology, 126 (1990) 1527-1533.
17. Busby, W.H., Snyder, D.K. and Clemmons, D.R., Radioimmunoassay of a 26,000-dalton plasma insulin-like growth factor binding protein: control by nutritional variables, J. Clin. Endocrinol. Metab., 67 (1988) 1225-1230.
18. DeMellow, J.S.M. and Baxter, R.C., Growth hormone dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates the IGF-1 stimulated DNA synthesis in human skin fibrobtasts, Biochem. Biophys. Res. Commun., 156 (1988) 199-204.
19. Elgin, R.G., Busby, W.H. and Clemmons, D.R., An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-1, Proc. Natl. Acad. Sci. USA, 84 (1987) 3254-3258.
20. Conover, C.A., Glycosylation of insulin-like growth factor binding protein-3 (IGFBP-3) is not required for potentiation of IFG-1 action: evidence for processing of cell bound IGFBP-3, Endocrinology, 129 (1991) 3259-3268.
21. Cohen, P., Lamson, G., Okajima, T. and Rosenfeld, R.C., Transfection of the human insulin-like growth factor binding protein-3 gene into Balb/c fibroblasts inhibits cellular growth, Mol. Endocrinol., 7 (1993) 380-386.
22. Valentinis, B., Bhala, A., DeAngelis, T., Baserga, R. and Cohen, P., The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-1 receptor gene, Mol. Endocrinol., 9 (1995) 361-367.
23. Fant, M., Munro, H.N. and Moses, A.C., An autocrine/paracrine role for insulin-like growth factors (IGFs) in the regulation of human placental growth, J. Clin. Endocrinol. Metab., 63 (1986) 499-505.
24. Fant, M., Munro, H. and Moses, A.C., Production of insulin-like growth factor binding protein(s) (IGF-BPs) by human placenta: variation with gestational age, Placenta, 9 (1988) 397-407.
25. Hunter, W.M. and Greenwood, F.C., Preparation of iodine-131-labelled human growth hormone of high specific activity, Nature (Lond.), 194 (1962) 494-496.
26. Rechler, M.M., Podskalny, J.M. and Nissley, S.P., Characterization of the binding of multiplication stimulating activily (MSA) to a receptor for growth polypeptides in chick embryo fibroblasts, J. Biol. Chem., 252 (1977) 3898-3910.
27. Hossenlopp, P., Seurin, D., Segovia-Quinson, B., Hardouin, S. and Binoux, M., Analysis of insulin-like growth factor binding proteins using Western blotting: use of the method for titration of the binding proteins and competitive binding studies, Anal. Biochem., 154 (1986) 138-143.
28. Chirgwin, J.M., Przybyla, A.E., MacDonald, R.J. and Rutter, W.J., Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease, Biochemistry, 18 (1979) 525294-525299.
29. Chomczynski, P. and Sacchi, N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal. Biochem., 162 (1987) 156-159.
30. Fant, M.E., Nanu, L. and Word, R.A., A potential role for endothelin-1 in human placental growth: interactions with the insulin-like growth factor family of peptides, J. Clin. Endocrinol. Metab., 74 (1992) 1158-1163.
31. Villaudy J., Blat C, Drop SLS, golde A and Harel L. 1994 difference in biological effects between insulin-like growth factor binding protein 1 and 3, Growth Factors 10, 107-114.
32. Tollefsen, S.E., Heath-Monnig, E., Cascieri, M.A., Bayne, M.L. and Daughaday, W., Endogenous insulin-like growth factor (IGF) binding proteins cause IGF-1 resistance in cultured fibroblasts from a patient with short stature, J. Clin. Invest., 87 (1991) 1241-1250.
33. Radulescu, R.T. and Wendtner, C.M., Hormone and growth factor subunits: a novel perveption of cell growth regulation, J. Endocrinol., 139 (1993) 1-7.
34. Radulescu, R.T. and Wendtner, C.M., Proposed interaction between insulin and retinoblastoma protein, J. Mol. Recog., 5 (1992) 133-137.